Screener
Aquestive Therapeutics, Inc. AQST Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | $13,819 | $10,003 | $28,265 | $18,723 |
| Costs and expenses: | ||||
| Total Manufacture and Supply Expenses | 4,017 | 4,561 | 7,486 | 8,213 |
| R&D Project expenses: | ||||
| Anaphylm project expenses | 1,055 | 1,204 | 2,140 | 3,692 |
| AQST-108 project expenses | 152 | 190 | 710 | 385 |
| R&D other expenses: | ||||
| Personnel costs1 | 2,181 | 2,218 | 4,423 | 4,350 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s business segments — revenue?
- Aquestive Therapeutics, Inc. (AQST) reported business segments — revenue of $13.82M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s business segments — revenue changed year-over-year?
- Aquestive Therapeutics, Inc.'s business segments — revenue increased by 38.1% year-over-year, from $10M to $13.82M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s business segments — revenue?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s business segments — revenue has grown at a -6.2% compound annual growth rate (CAGR), from $50.58M to $44.55M.
- What does business segments — revenue mean?
- Represents the total gross inflow of economic benefits arising from the ordinary operating activities of the reportable business segment. This metric reflects the market demand for the segment's specialized pharmaceutical products and services. It serves as a primary indicator of the segment's top-line growth and commercial success.
Ask your AI about Aquestive Therapeutics, Inc.'s business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude